Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction

Hypertension. 2001 Feb;37(2 Pt 2):529-34. doi: 10.1161/01.hyp.37.2.529.

Abstract

There is evidence in humans that hypertension and aging similarly impair endothelial function, although the mechanism remains unclear. Superoxide anion (O(2)(-)) is a major determinant of nitric oxide (NO) bioavailability and thus endothelial function. We sought to determine the relationship between endothelial function, O(2)(-), and age in normotensive Wistar-Kyoto (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). Aortic rings were removed from female WKY and SHRSP at 3 to 4 months (young) and 9 to 12 months (old). O(2)(-) generation by aortic rings was measured before and after removal of the endothelium or incubation with N(G) nitro-L-arginine methyl ester, diphenyleneiodonium, or apocynin. Levels of p22phox were studied with immunohistochemistry and used as a marker of NAD(P)H oxidase expression. NO bioavailability was significantly lower in old WKY compared with young WKY (P=0.0009) and in old SHRSP compared with young SHRSP (P=0.005). O(2)(-) generation was significantly greater in old WKY compared with young WKY (P=0.0001). Removal of the endothelium and N(G) nitro-L-arginine methyl ester treatment resulted in a significant reduction in O(2)(-) generation in old SHRSP (P=0.009 and 0.001, respectively). Diphenyleneiodonium significantly reduced O(2)(-) generation in 12-month WKY (P=0.008) and 12-month SHRSP (P=0.009). Apocynin attenuated O(2)(-) generation by older WKY (P=0.038) and SHRSP (P=0.028). p22phox was increased in older animals compared with young. We conclude that NO bioavailability decreases with age in female WKY and SHRSP. O(2)(-) generation increases with age in WKY and is higher in SHRSP and may contribute to the reduced NO by scavenging. NAD(P)H oxidase may contribute to the age-related increase in O(2)(-).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Aging*
  • Animals
  • Aorta
  • Blood Pressure
  • Carotid Arteries
  • Endothelium, Vascular / physiopathology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Hypertension / metabolism
  • Hypertension / physiopathology*
  • Immunohistochemistry
  • In Vitro Techniques
  • Luminescent Measurements
  • Membrane Transport Proteins*
  • NADPH Dehydrogenase / analysis
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / biosynthesis
  • Onium Compounds / pharmacology
  • Phosphoproteins / analysis
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Superoxides / metabolism*

Substances

  • Acetophenones
  • Enzyme Inhibitors
  • Membrane Transport Proteins
  • Onium Compounds
  • Phosphoproteins
  • Superoxides
  • Nitric Oxide
  • diphenyleneiodonium
  • acetovanillone
  • NADPH Oxidases
  • CYBA protein, human
  • NADPH Dehydrogenase
  • NG-Nitroarginine Methyl Ester